Books in Gene therapy

Adenoviral Vectors for Gene Therapy

3rd Edition
April 9, 2025
David T. Curiel + 1 more
English
Hardback
9 7 8 0 3 2 3 8 9 8 2 1 8
eBook
9 7 8 0 3 2 3 9 5 8 1 4 1

Adenoviral Vectors for Gene Therapy, Third Edition, provides detailed, comprehensive coverage of gene delivery vehicles based on the adenovirus that is emerging as an important tool in gene therapy. These exciting new therapeutic agents have great potential for the treatment of disease, as platforms for gene therapy and gene editing, as well as for oncology approaches, making them class leading agents in the gene-advanced therapies arena.The fully updated and expanded third edition covers the basic biology of adenoviruses and highlights the potential use of adenoviral vectors for the treatment of disease, including their construction, propagation, and purification, cutting-edge vectorology, and the use of adenoviral vectors in preclinical animal models. The book also considers the regulatory issues surrounding human clinical gene therapy trials. New chapters include adenoviral vaccines for veterinary applications, adenoviruses for gene editing, nonhuman primate adenoviruses, COVID-19 vaccines, vaccine applications, and oncolytic adenoviruses for antitumor immunization. This broad scope of information provides a solid overview of the field, allowing the reader to gain a complete understanding of the development and use of adenoviral vectors.

Adenoviral Vectors for Gene Therapy

2nd Edition
March 10, 2016
David T. Curiel
English
Hardback
9 7 8 0 1 2 8 0 0 2 7 6 6
eBook
9 7 8 0 1 2 8 0 0 5 1 0 1

Adenoviral Vectors for Gene Therapy, Second Edition provides detailed, comprehensive coverage of the gene delivery vehicles that are based on the adenovirus that is emerging as an important tool in gene therapy. These exciting new therapeutic agents have great potential for the treatment of disease, making gene therapy a fast-growing field for research. This book presents topics ranging from the basic biology of adenoviruses, through the construction and purification of adenoviral vectors, cutting-edge vectorology, and the use of adenoviral vectors in preclinical animal models, with final consideration of the regulatory issues surrounding human clinical gene therapy trials. This broad scope of information provides a solid overview of the field, allowing the reader to gain a complete understanding of the development and use of adenoviral vectors.

Nonviral Vectors for Gene Therapy

1st Edition
Volume 88
November 12, 2014
Leaf Huang + 2 more
English
Hardback
9 7 8 0 1 2 8 0 0 1 4 8 6
eBook
9 7 8 0 1 2 8 0 0 3 6 7 1

The field of genetics is rapidly evolving, and new medical breakthroughs are occurring as a result of advances in our knowledge of genetics. Advances in Genetics continually publishes important reviews of the broadest interest to geneticists and their colleagues in affiliated disciplines.

Gene therapy

1st Edition
October 31, 2013
Surendra Nimesh
English
Hardback
9 7 8 1 9 0 7 5 6 8 4 0 4
eBook
9 7 8 1 9 0 8 8 1 8 6 4 5

Gene therapy is emerging as a new class of therapeutics for the treatment of inherited and acquired diseases. However, poor cellular uptake and instability of DNA in the physiological milieu limits its therapeutic potential, hence a vector which can protect and efficiently transport DNA to the target cells must be developed. Nanotechnology-based non-viral vectors have been proposed as potential candidates. Various polymeric nanoparticles have been shown to be suitable, with high cellular uptake efficiencies and reduced cytotoxicity. These delivery vectors form condensed complexes with DNA which result in shielding against enzymatic degradation and enhanced cellular targeting. Advantages including easy manipulatibility, high stability, low cost and high payload, mean that nanoparticles from various polymers have been exploited. Gene therapy gives a systematic account of the many aspects of nanotechnology mediated gene therapy, from the preparation of nanoparticles to physicochemical characterization, and follows with applications in in vitro and in vivo models. This book emphasizes the various aspects of nanotechnology-based gene therapy, with initial chapters detailing the tools and techniques available for preparation and in vitro and in vivo characterization of nanoparticles. Later chapters provide exhaustive details on polymeric systems employed for gene therapy.

Gene Therapy of Cancer

3rd Edition
August 28, 2013
Edmund C. Lattime + 1 more
English
Hardback
9 7 8 0 1 2 3 9 4 2 9 5 1
eBook
9 7 8 0 1 2 3 9 4 6 3 2 4

Gene therapy as a treatment for cancer is at a critical point in its evolution. Exciting new developments in gene targeting and vector technology, coupled with results from the first generation of preclinical and clinical studies have led to the design and testing of new therapeutic approaches. The Third Edition of Gene Therapy of Cancer provides crucial updates on the basic and applied sciences of gene therapy. It offers a comprehensive assessment of the field including the areas of suicide gene therapy, oncogene and suppressor gene targeting, immunotherapy, drug resistance gene therapy, and the genetic modification of stem cells. Researchers at all levels of development, from basic laboratory investigators to clinical practitioners, will find this book to be instructive. Cancer gene therapy, like cancer therapy in general, is evolving rapidly, testing new concepts, targets and pathways, evoking new technologies, and passing new regulatory hurdles. Its essence, however, has not changed: the hope and challenges of returning altered genes to normal, using targeted gene expression to alter the function of both tumor and microenvironment, and in some cases normal cells, and delivering functionally important genes to specific cell types to increase sensitivity to killing or to protect normal cells from cancer therapies. In some instances, gene therapy for cancer forms a continuum from gene repair through the use of molecularly modified cells; the use of viral and non-viral vector based gene delivery to both tumor and tumor microenvironment; the use of viral and gene based vaccines; and development of new gene-based therapeutics. The unique mechanistically chosen vector platforms are at the heart of this technology because they allow for direct and selective cell death and transient to sustained delivery of vaccine molecules or molecules that affect the microenvironment, vasculature, or the immune response.

Gene Transfer Vectors for Clinical Application

1st Edition
Volume 507
March 6, 2012
Theodore C. Friedman
English
Hardback
9 7 8 0 1 2 3 8 6 5 0 9 0
eBook
9 7 8 0 1 2 3 8 6 5 1 0 6

This volume of Methods in Enzymology looks at Gene Transfer Vectors for Clinical Application. The chapters provide an invaluable resource for academics, researchers and students alike. With an international board of authors, this volume covers such topics as General principles of retrovirus vector design, Chronic granulomatous disease (CGD), Gene therapy for blindness, and Retrovirus genetic strategy and vector design.

Gene Therapy: Prospective Technology assessment in its societal context

1st Edition
July 21, 2006
Jörg Niewöhner + 1 more
English
Hardback
9 7 8 0 4 4 4 5 2 8 0 6 3
eBook
9 7 8 0 0 8 0 4 7 0 9 3 1

This book presents work that has been conducted as part of the research project "Discourse on ethical questions of biomedicine" of the interdisciplinary Working Group Bioethics and Science Communication at the Max-Delbrueck-Center for Molecular Medicine (MDC)in Berlin-Buch, Germany. This book offers ground-breaking ideas on how the daily interworking of cutting-edge biomedical research assess the broader social context and its communication to stakeholders and the public. Editors cover three aspects: Scientific, Ethical and Legal, and Perception and Communication. This work establishes an international and interdisciplinary network of excellent researchers at the beginning of their careers, who brilliantly integrate their work into the different perspectives on gene therapy from the natural and social sciences, as well as the humanities and law.

Nonviral Vectors for Gene Therapy, Part 2

2nd Edition
Volume 54
July 7, 2005
Leaf Huang + 2 more
English
Hardback
9 7 8 0 1 2 0 1 7 6 5 4 0
eBook
9 7 8 0 0 8 0 4 5 6 1 3 3

The field of non-viral vector research has rapidly progressed since the publication of the first edition. This new edition is expanded to two separate volumes that contain in-depth discussions of different non-viral approaches, including cationic liposomes and polymers, naked DNA and various physical methods of delivery, as well as a comprehensive coverage of the molecular biological designs of the plasmid DNA for reduced toxicity, prolonged expression and tissue or disease specific genes. New developments such as the toxicity of the non-viral vectors and recent advances in nucleic acid therapeutics are fully covered in these volumes.

Gene Therapy Methods

1st Edition
Volume 346
February 22, 2002
M. Ian Phillips
English
Hardback
9 7 8 0 1 2 1 8 2 2 4 7 7
eBook
9 7 8 0 0 8 0 4 9 6 9 4 8

This volume in the prestigious Methods in Enzymology series discusses methods currently used in preclinical and clinical gene therapy. Subjects covered in this book, such as the use of adeno-associated virus delivery for treatment of Parkinson's disease, are topical and are presented in the methods-oriented style popularized by this series.

Life Sciences

Physical Sciences & Engineering

Social Sciences & Humanities

Health

Books in Gene therapy

Adenoviral Vectors for Gene Therapy

Adenoviral Vectors for Gene Therapy

Nonviral Vectors for Gene Therapy

Gene therapy

Gene Therapy of Cancer

Gene Transfer Vectors for Clinical Application

Gene Therapy: Prospective Technology assessment in its societal context

Nonviral Vectors for Gene Therapy, Part 2

Gene Therapy Methods